Mark Levy, Derivatively on Behalf of Immunogen Inc. v. Southbrook International Investments, Ltd. And Immunogen, Inc., Nominal-Defendant-Appellee

U.S. Court of Appeals, Second Circuit · Decided 2001-08-23

Cited by 131 later decision(s) in our corpus · see the citation network in Lexace

From the opinion

PARKER, Circuit Judge: Plaintiff-appellant, Mark Levy (“Levy”), is a shareholder of ImmunoGen, Inc (“Im-munoGen”). He brings this shareholder derivative action alleging that defendant, Southbrook International Investment, Ltd. (“Southbrook”), by virtue of its ownership of ImmunoGen convertible preferred shares, is a more than 10% beneficial owner of ImmunoGen common stock and real…

Read the full opinion (source) ↗

Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Citation figures are counts of later citing opinions in our corpus and may be incomplete; always read and Shepardize the full opinion before relying on it.